Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: A study based on coronary angiography

Atherosclerosis

Volumn 159, Issue 1, 2001, Pages 153-163

  Goto, Akitomo ^a   Sasai, Kanna ^a   Suzuki, Shogo ^a   Fukutomi, Tatsuya ^a   Ito, Shigenori ^a   Matsushita, Toyoaki ^b   Okamoto, Mitsuhiro ^b   Suzuki, Takahiko ^c   Itoh, Makoto ^a   Okumura Noji, Kuniko ^a   Yokoyama, Shinji ^a,d  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Owari Perfectural Hospital Cardiovascular Center   (Japan)

^c National Toyohashi Higashi Hospital   (Japan)

^d Department of Surgery   (Japan)

Author keywords

Atherosclerosis; CETP; Coronary heart disease; Gene polymorphism; HDL; LDL

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASSAY; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTECTION;

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; JAPAN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC;

EID: 0034750753     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00476-2     Document Type: Article

References (60)

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study
2. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study
3. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
4. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
5. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
6. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study
7. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
8. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein: Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies
9. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
10. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene
11. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits
12. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
13. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression
14. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
15. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis
16. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
17. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase
18. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity
19. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease
20. CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese
21. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia
22. Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: Plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients
23. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia
24. Elevated HDL cholesterol is a risk factor for ishemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
25. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men
26. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
27. Association of cholesteryl ester transfer protein -TaqIB polymorphism with variation in lipoprotein subclasses and coronary heart disease risk
28. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients
29. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population
30. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol
31. Current state of and recent trends in serum lipid levels in the general Japanese population. Research Committee on Serum Lipid Level Survey 1990 in Japan
32. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association
33. Development of coronary heart disease in familial hypercholesterolemia
34. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
35. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population - Relation between the mutation and hyperalphalipoproteinemia
36. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
37. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction
38. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations
39. CETP and atheroscelrosis
40. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels
41. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine
42. Cholesteryl ester transfer in hypercholesterolaemia: Fasting and postprandial studies with and without pravastatin
43. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans
44. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins
45. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency
46. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins
47. Plasma lipid transfer activities in hyper-high-density lipoprotein cholesterolemic and healthy control subjects
48. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase
49. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver
50. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA
51. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia
52. Cholesterol and lipids in the risk of coronary artery disease - The Framingham Heart Study
53. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
54. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
55. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
56. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
57. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
58. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
59. Atherosclerosis in angiographically 'normal' coronary artery reference segments: An intravascular ultrasound study with clinical correlations
60. Coronary plaque disruption